Drugs / LEO 153339
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04883333 | May 2021 → Jul 2022 | — | LEO Pharma | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LEO 153339 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04883333 ↗ |